Profound Medical Corp
TSX:PRN
Profound Medical Corp
Change in Working Capital
Profound Medical Corp
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Change in Working Capital
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
|
|
Titan Medical Inc
TSX:TMD
|
Change in Working Capital
-$2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Change in Working Capital
CA$1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Change in Working Capital
CA$1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Change in Working Capital
-CA$3.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
1%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Change in Working Capital
CA$2m
|
CAGR 3-Years
137%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Change in Working Capital?
Change in Working Capital
2m
USD
Based on the financial report for Mar 31, 2025, Profound Medical Corp's Change in Working Capital amounts to 2m USD.
What is Profound Medical Corp's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
1%
Over the last year, the Change in Working Capital growth was 34%.
You don't have any saved screeners yet